Background And Purpose: Recanalization of post-embolization cerebral aneurysms remains a serious problem that influences treatment outcomes. Matrix2 is a bioactive, bio-absorbable, detachable coil that was developed to reduce the risk of recanalization. We examined the short-term efficacy of the Matrix2 coil system, and evaluated the temporal profile of tissue proliferation in a swine experimental aneurysm model compared with the bare platinum (BP) coil.
Materials And Methods: Thirty-six experimental aneurysms were created in 18 swine. All aneurysms were tightly packed with Matrix2 or BP coils. Comparative histologic and morphologic analyses were undertaken 1, 2 and 4 weeks post-embolization.
Results: Endothelial-like cells were observed partially lining the aneurysmal opening one week post-embolization with both coil types. At two and four weeks post-embolization, the aneurysms treated with Matrix2 coils had more extensive areas of organized thrombus than those packed with BP coils, but the numbers of functional proliferating endothelial cells identified by immunohistochemistry in the tissue were broadly comparable between the groups. Moreover, morphological analysis suggested there were more mature endothelial cells in aneurysms treated with bare platinum rather than Matrix2 coils.
Conclusions: Our results indicate that aneurysms embolized with Matrix2 coils build thicker scaffolds for endothelialization, but this is not necessarily evidence of earlier tissue proliferation and maturation than those embolized with BP coils. Matrix2 coils may not be superior to BP coils for preventing aneurysmal recanalization after endovascular treatment of cerebral aneurysms.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.neurad.2015.04.003 | DOI Listing |
J Neurointerv Surg
October 2021
Neurointerventional Surgery, Radiology, and Neurosurgery, Medical University of South Carolina, Charleston, South Carolina, USA.
Background: No randomized trial of intracranial aneurysm coiling has compared long-term efficacy of polymer-modified coils to bare metal coils (BMCs). We report 5-year results comparing Matrix coils to BMCs. The primary objective was to compare the rates of target aneurysm recurrence (TAR) at 12 months.
View Article and Find Full Text PDFJ Neuroradiol
February 2016
Department of Neurosurgery, Juntendo University School of Medicine, Tokyo, Japan.
Background And Purpose: Recanalization of post-embolization cerebral aneurysms remains a serious problem that influences treatment outcomes. Matrix2 is a bioactive, bio-absorbable, detachable coil that was developed to reduce the risk of recanalization. We examined the short-term efficacy of the Matrix2 coil system, and evaluated the temporal profile of tissue proliferation in a swine experimental aneurysm model compared with the bare platinum (BP) coil.
View Article and Find Full Text PDFAJNR Am J Neuroradiol
May 2014
Departments of Neurointerventional Surgery, Radiology, and Neurosurgery (A.S.T.), Medical University of South Carolina, Charleston, South Carolina.
Background And Purpose: The ability of polymer-modified coils to promote stable aneurysm occlusion after endovascular treatment is not well-documented. Angiographic aneurysm recurrence is widely used as a surrogate for treatment failure, but studies documenting the correlation of angiographic recurrence with clinical failure are limited. This trial compares the effectiveness of Matrix(2) polyglycolic/polylactic acid biopolymer-modified coils with bare metal coils and correlates the angiographic findings with clinical failure (ie, target aneurysm recurrence), a composite end point that includes any incident of posttreatment aneurysm rupture, retreatment, or unexplained death.
View Article and Find Full Text PDFClin Neurol Neurosurg
May 2013
Department of Neurosurgery, Konkuk University School of Medicine, Seoul, Republic of Korea.
Objective: We analyzed the angiographic results of tiny aneurysms treated with various kinds of single coils including polyglycolic-polylactic acid (PGLA)-coated coils.
Methods: Forty aneurysms with diameters measuring less than 4mm were treated with a single bare platinum, Matrix1, or Matrix2 coil. Most of the aneurysms were treated with a 2 mm diameter coil, except for seven treated with a 3 mm coil, four treated with a 2.
J Neuroradiol
December 2012
Division of Interventional Neuroradiology, Hôpital Gui de Chauliac, CHU de Montpellier, 80, avenue Augustin-Fliche, 34295 Montpellier, France.
Objective: To evaluate 1 year results of endovascular treatment (EVT) of intracranial aneurisms using Matrix second generation detachable coils (MSG(®)).
Patients And Methods: Between January and December 2006, 32 patients with 32 intracranial aneurisms were treated by coiling using MSG(®), with a minimum follow-up of 1 year. Data were acquired prospectively.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!